Deere & Company (DE) EPS Estimated At $1.09; Boston Scientific (BSX) Sellers Decreased By 4.61% Their Shorts

January 22, 2018 - By Stephen Andrade

Analysts expect Deere & Company (NYSE:DE) to report $1.09 EPS on February, 16.They anticipate $0.48 EPS change or 78.69% from last quarter’s $0.61 EPS. DE’s profit would be $350.21M giving it 39.02 P/E if the $1.09 EPS is correct. After having $1.57 EPS previously, Deere & Company’s analysts see -30.57% EPS growth. The stock decreased 0.12% or $0.2 during the last trading session, reaching $170.12. About 67,452 shares traded. Deere & Company (NYSE:DE) has risen 46.99% since January 22, 2017 and is uptrending. It has outperformed by 30.29% the S&P500.

Boston Scientific Corporation (NYSE:BSX) had a decrease of 4.61% in short interest. BSX’s SI was 15.06M shares in January as released by FINRA. Its down 4.61% from 15.79 million shares previously. With 10.72M avg volume, 1 days are for Boston Scientific Corporation (NYSE:BSX)’s short sellers to cover BSX’s short positions. The SI to Boston Scientific Corporation’s float is 1.11%. The stock decreased 0.72% or $0.2 during the last trading session, reaching $27.45. About 222,595 shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since January 22, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 85 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by SunTrust on Thursday, February 25. Stifel Nicolaus maintained Boston Scientific Corporation (NYSE:BSX) rating on Monday, September 25. Stifel Nicolaus has “Buy” rating and $32.0 target. The stock of Boston Scientific Corporation (NYSE:BSX) has “Top Pick” rating given on Friday, January 5 by RBC Capital Markets. Needham maintained the stock with “Buy” rating in Wednesday, June 28 report. The firm has “Strong Buy” rating given on Monday, October 5 by Raymond James. Citigroup maintained the shares of BSX in report on Thursday, October 6 with “Buy” rating. The company was maintained on Thursday, August 31 by BMO Capital Markets. Jefferies maintained Boston Scientific Corporation (NYSE:BSX) on Friday, July 28 with “Hold” rating. As per Friday, February 3, the company rating was maintained by Needham. The firm earned “Buy” rating on Thursday, February 25 by Suntrust Robinson.

Boston Scientific Corporation develops, makes, and markets medical devices for use in various interventional medical specialties worldwide. The company has market cap of $37.69 billion. It operates through three divisions: Cardiovascular, Rhythm Management, and MedSurg. It has a 45 P/E ratio. The firm offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems.

Investors sentiment increased to 1.04 in 2017 Q3. Its up 0.01, from 1.03 in 2017Q2. It improved, as 33 investors sold Boston Scientific Corporation shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. 165,040 were accumulated by Amalgamated Commercial Bank. Virtus Invest Advisers accumulated 28,995 shares. 49,975 are owned by Moors Cabot Incorporated. Sei Invests holds 0.57% or 5.51M shares in its portfolio. Banced Corp stated it has 0.86% in Boston Scientific Corporation (NYSE:BSX). Ing Groep Nv stated it has 48,414 shares. Sumitomo Mitsui Asset Mgmt Company holds 0.08% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 167,112 shares. Moreover, Ls Inv Advsr Llc has 0.07% invested in Boston Scientific Corporation (NYSE:BSX) for 40,621 shares. Alexandria Ltd Com holds 0% or 238 shares in its portfolio. Dynamic Capital Ltd invested in 46,345 shares or 0.39% of the stock. Huntington Financial Bank stated it has 60,712 shares. 82,480 were reported by Pnc Fin Grp. The Ontario – Canada-based Toronto Dominion State Bank has invested 0.05% in Boston Scientific Corporation (NYSE:BSX). Price T Rowe Assoc Md owns 2.41M shares. California Public Employees Retirement System accumulated 2.90 million shares or 0.13% of the stock.

Since August 1, 2017, it had 0 buys, and 13 sales for $15.16 million activity. Nanavaty Maulik sold 57,031 shares worth $1.56 million. The insider Pierce David A sold 5,152 shares worth $139,104. The insider Phalen Michael P. sold $440,547. 347,137 Boston Scientific Corporation (NYSE:BSX) shares with value of $10.11 million were sold by Bose Supratim. $208,328 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Sorenson John Bradley on Wednesday, August 2. 10,000 Boston Scientific Corporation (NYSE:BSX) shares with value of $266,650 were sold by Pratt Timothy A.. Carruthers Wendy sold $332,584 worth of stock.

Since August 4, 2017, it had 0 insider purchases, and 14 insider sales for $30.44 million activity. May John C II also sold $2.81 million worth of Deere & Company (NYSE:DE) on Monday, October 2. Guinn Max A had sold 5,000 shares worth $654,450 on Tuesday, August 8. Reed Cory J also sold $972,253 worth of Deere & Company (NYSE:DE) on Monday, December 11. 22,095 Deere & Company (NYSE:DE) shares with value of $3.76 million were sold by Field James M.. $1.69M worth of Deere & Company (NYSE:DE) was sold by Jones Mary K.W.. von Pentz Markwart had sold 46,457 shares worth $5.42 million on Tuesday, August 22. 8,015 Deere & Company (NYSE:DE) shares with value of $1.04M were sold by Gilles Jean H.

Investors sentiment decreased to 0.93 in Q3 2017. Its down 0.07, from 1 in 2017Q2. It turned negative, as 64 investors sold Deere & Company shares while 312 reduced holdings. 69 funds opened positions while 281 raised stakes. 213.38 million shares or 1.82% more from 209.56 million shares in 2017Q2 were reported. Proshare Advsrs Ltd holds 0.05% of its portfolio in Deere & Company (NYSE:DE) for 40,521 shares. Frontier Mngmt owns 3,757 shares or 0.04% of their US portfolio. Mcf Advisors Limited Liability Corp holds 0.03% of its portfolio in Deere & Company (NYSE:DE) for 1,165 shares. Thompson Rubinstein Mgmt Or invested 2.3% of its portfolio in Deere & Company (NYSE:DE). Sterling Cap Limited Com stated it has 5,142 shares. Deutsche Financial Bank Ag, a Germany-based fund reported 411,805 shares. Cwm Limited Liability Corp reported 0.01% of its portfolio in Deere & Company (NYSE:DE). 4,667 are held by Tradewinds Capital Llc. Butensky Cohen Fincl Security reported 1.52% of its portfolio in Deere & Company (NYSE:DE). 65,311 were accumulated by Sg Americas Secs Limited Co. Gotham Asset Mgmt Ltd invested in 0.11% or 57,103 shares. World Asset Management holds 0.14% or 33,077 shares in its portfolio. Voya Inv Mngmt Ltd Liability has invested 0.26% in Deere & Company (NYSE:DE). Crestpoint Mngmt Lc stated it has 3,300 shares or 0.18% of all its holdings. Van Cleef Asset Managementinc invested in 0.28% or 8,122 shares.

Among 29 analysts covering Deere & Company (NYSE:DE), 13 have Buy rating, 3 Sell and 13 Hold. Therefore 45% are positive. Deere & Company had 115 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Deere & Company (NYSE:DE) earned “Hold” rating by Credit Suisse on Tuesday, January 9. As per Wednesday, January 10, the company rating was upgraded by RBC Capital Markets. The firm earned “Buy” rating on Wednesday, June 7 by Citigroup. The firm earned “Sector Perform” rating on Monday, August 22 by RBC Capital Markets. The stock of Deere & Company (NYSE:DE) earned “Hold” rating by RBC Capital Markets on Friday, June 23. RBC Capital Markets maintained it with “Hold” rating and $13300 target in Tuesday, July 25 report. The firm has “Hold” rating by RBC Capital Markets given on Monday, August 21. The firm has “Buy” rating given on Tuesday, August 25 by Deutsche Bank. The rating was maintained by Morgan Stanley with “Underweight” on Monday, August 24. The rating was initiated by Societe Generale on Monday, November 16 with “Hold”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.